Parish S Vaidya, MD
Physical Medicine and Rehabilitation · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 36
- 9 carriers
- Office
- 1
Offices
1 location · James Petros MD Inc · 21 clinicians in this group
Plans that list them
36 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Vaidya’s office at (408) 528-8833 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
36 of 36 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A105629 · Current
Licensed to practise in California · since 2008 · expires 2028-03-31 · Temple University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Trinity Surgery Center, LLC dba Trinity Surgery CenterAmbulatory Surgery Center · Saratoga, CA1% owner since 2016 · accredited by AAAHCAccreditation Renewed2 inspections, 1 with deficiencies · last 2024-01-10
State licence records
1 licence
- Texas M6924Physician License · since 2007 · expires 2016-08-31Canc Non-RenewalNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Original Medicare doctor bills
$138,927
Medicare paid this office $138,927 for 137 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 105 | $32,075 | $104 |
| Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | 96 | $26,888 | $70 |
| Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | 112 | $19,533 | $68 |
| Long return visit (40+ min) | 48 | $11,022 | $130 |
| Administration of psychological or neuropsychological test, first 30 minutes | 89 | $4,976 | $35 |
See all 14 services
| Return visit (30+ min) | 105 | $32,075 | $104 |
| Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | 96 | $26,888 | $70 |
| Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | 112 | $19,533 | $68 |
| Long return visit (40+ min) | 48 | $11,022 | $130 |
| Administration of psychological or neuropsychological test, first 30 minutes | 89 | $4,976 | $35 |
| Principal care management services for a single high-risk disease, each additional 30 minutes provided personally by qualified health care professional, per calendar month | 38 | $3,818 | $52 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 27 | $3,544 | $122 |
| New patient visit (45+ min) | 23 | $3,285 | $143 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 89 | $2,885 | $13 |
| Ultrasonic guidance for needle placement | 17 | $1,581 | $53 |
| Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | 21 | $1,341 | $45 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 12 | $1,206 | $93 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 18 | $1,080 | $54 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 24 | $74 | None |
Who their Medicare patients are
137 Original Medicare patients in 2024. Average age 75 · Women 69% · Also on Medicaid 15% · Health risk score 1.27. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 1.53.
Conditions among them: High blood pressure 75% · Coronary heart disease 31% · Diabetes 28% · Depression 27% · Chronic kidney disease 20% · Cancer 17% · Atrial fibrillation 17% · COPD 15% · Heart failure 13%.
The office billed $2,165,899, Medicare allowed $183,100 and paid $138,927; for 1,994 services of 60 kinds; $83 of it was for drugs given in the office and $138,844 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 137 | 1,994 | 75 | 1.27 | $2,165,899 | $138,927 |
| 2023 | 259 | 3,078 | 74 | 1.17 | $3,603,885 | $262,082 |
| 2022 | 262 | 2,145 | 73 | 1.11 | $1,717,461 | $206,527 |
| 2021 | 241 | 1,932 | 73 | 1.10 | $1,806,111 | $169,031 |
| 2020 | 210 | 1,974 | 73 | 1.20 | $1,348,429 | $146,591 |
| 2019 | 240 | 1,478 | 72 | 1.12 | $708,320 | $127,783 |
| 2018 | 222 | 1,543 | 71 | 1.27 | $369,922 | $111,123 |
| 2017 | 230 | 2,142 | 71 | 1.24 | $203,886 | $104,747 |
| 2016 | 130 | 765 | 70 | 1.30 | $101,750 | $46,653 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 23 services
| Return visit (30+ min) | 194 | $68,953 | $119 |
| Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | 202 | $45,898 | $74 |
| Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | 109 | $27,024 | $75 |
| Long return visit (40+ min) | 71 | $21,636 | $166 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 63 | $10,199 | $129 |
| Insertion of peripheral nerve neurostimulator electrode through skin | 18 | $9,200 | $224 |
| New patient visit (45+ min) | 55 | $8,238 | $150 |
| Administration of psychological or neuropsychological test, first 30 minutes | 124 | $8,147 | $42 |
| Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | 71 | $7,167 | $41 |
| Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | 11 | $5,832 | $530 |
| Short return visit (20+ min) | 33 | $3,354 | $80 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 17 | $2,931 | $105 |
| Ultrasonic guidance for needle placement | 29 | $2,769 | $50 |
| New patient visit (60+ min) | 12 | $2,394 | $199 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 36 | $2,329 | $53 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 17 | $2,285 | $74 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 15 | $2,218 | $106 |
| Principal care management services for a single high-risk disease, each additional 30 minutes provided personally by qualified health care professional, per calendar month | 20 | $2,062 | $54 |
| Injection of trigger points, 3 or more muscles | 18 | $1,939 | $50 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 13 | $1,118 | $59 |
| Electronic analysis of implanted neurostimulator generator with simple spinal cord or peripheral nerve stimulator programming | 12 | $807 | $45 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 13 | $478 | $32 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 40 | $169 | None |
2022: 19 services
| Return visit (30+ min) | 196 | $71,967 | $115 |
| Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | 183 | $36,297 | $76 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 58 | $9,520 | $125 |
| New patient visit (45+ min) | 63 | $9,048 | $144 |
| Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | 16 | $8,668 | $542 |
| Short return visit (20+ min) | 63 | $8,152 | $80 |
| Administration of psychological or neuropsychological test, first 30 minutes | 114 | $6,744 | $42 |
| Muscle electrical test | 22 | $4,086 | $105 |
| Long return visit (40+ min) | 17 | $3,097 | $163 |
| Nerve test | 13 | $2,959 | $228 |
| New patient visit (60+ min) | 14 | $2,680 | $191 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 13 | $2,299 | $115 |
| Injection of substance into middle or upper spine canal using imaging guidance | 16 | $1,768 | $98 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 46 | $1,710 | $32 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 15 | $1,620 | $108 |
| Principal care management services for a single high-risk disease, each additional 30 minutes provided personally by qualified health care professional, per calendar month | 16 | $1,448 | $54 |
| Ultrasonic guidance for needle placement | 18 | $1,305 | $48 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 18 | $1,020 | $51 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 38 | $115 | None |
2021: 20 services
| Return visit (30+ min) | 172 | $51,379 | $123 |
| Short return visit (20+ min) | 67 | $10,433 | $86 |
| New patient visit (45+ min) | 65 | $10,338 | $159 |
| Nerve test | 33 | $10,220 | $310 |
| Comprehensive care management services for a single high-risk disease, e.g., principal care management, at least 30 minutes of physician or other qualified health care professional time per calendar month with the following elements: one complex chronic co | 80 | $10,163 | $85 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 44 | $8,384 | $135 |
| Muscle electrical test | 35 | $7,092 | $107 |
| Administration of psychological or neuropsychological test, first 30 minutes | 93 | $4,855 | $46 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 54 | $2,819 | $36 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $2,486 | $113 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 26 | $2,159 | $58 |
| Injection of substance into middle or upper spine canal using imaging guidance | 17 | $2,110 | $100 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $1,607 | $89 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 11 | $1,478 | $114 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 11 | $1,290 | $92 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 21 | $941 | $34 |
| Ultrasonic guidance for needle placement | 13 | $878 | $59 |
| Fluoroscopic guidance for needle placement | 18 | $561 | $25 |
| Testing for presence of drug, read by direct observation | 11 | $151 | $13 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $64 | None |
2020: 19 services
| Return visit (30+ min) | 158 | $41,684 | $99 |
| Nerve test | 39 | $12,316 | $300 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 49 | $8,794 | $129 |
| Muscle electrical test | 42 | $8,633 | $100 |
| New patient visit (45+ min) | 53 | $7,888 | $149 |
| Short return visit (20+ min) | 54 | $5,805 | $72 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 54 | $2,812 | $37 |
| Extended patient service without direct patient contact, first hour | 22 | $2,390 | $104 |
| Mri scan of lower spinal canal without contrast | 33 | $2,299 | $66 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 29 | $2,127 | $49 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 12 | $1,717 | $90 |
| Injection of substance into middle or upper spine canal using imaging guidance | 11 | $1,413 | $101 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 12 | $1,332 | $89 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 12 | $834 | $36 |
| Mri scan of upper spinal canal without contrast | 11 | $761 | $69 |
| Fluoroscopic guidance for needle placement | 18 | $569 | $26 |
| Assessment of emotional or behavioral problems | 43 | $441 | $5 |
| Testing for presence of drug, read by direct observation | 13 | $187 | $12 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $66 | None |
2019: 19 services
| Return visit (30+ min) | 188 | $46,468 | $100 |
| New patient visit (45+ min) | 88 | $13,321 | $151 |
| Nerve test | 37 | $10,967 | $296 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 54 | $8,582 | $126 |
| Muscle electrical test | 43 | $7,493 | $95 |
| Extended patient service without direct patient contact, first hour | 38 | $4,048 | $96 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 43 | $2,830 | $54 |
| Mri scan of lower spinal canal without contrast | 31 | $2,201 | $67 |
| Extended office or other outpatient service, first hour | 18 | $2,186 | $115 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 17 | $2,088 | $104 |
| Injection of substance into middle or upper spine canal using imaging guidance | 13 | $1,669 | $98 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 11 | $1,338 | $84 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 17 | $1,271 | $31 |
| Short return visit (20+ min) | 12 | $918 | $71 |
| Ultrasonic guidance for needle placement | 16 | $770 | $32 |
| Assessment of emotional or behavioral problems | 58 | $618 | $5 |
| Testing for presence of drug, read by direct observation | 27 | $383 | $12 |
| Injection of drug or substance under skin or into muscle | 11 | $230 | $16 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $40 | None |
2018: 18 services
| Return visit (30+ min) | 140 | $43,792 | $96 |
| Short return visit (20+ min) | 96 | $11,412 | $63 |
| New patient visit (45+ min) | 68 | $9,954 | $146 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 50 | $7,581 | $117 |
| Extended patient service without direct patient contact, first hour | 53 | $5,661 | $98 |
| Nerve test | 16 | $4,294 | $268 |
| Muscle electrical test | 20 | $2,954 | $84 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 38 | $2,606 | $51 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 16 | $1,797 | $90 |
| New patient visit (30+ min) | 15 | $1,479 | $99 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 13 | $1,272 | $79 |
| Assessment of emotional or behavioral problems | 61 | $1,092 | $6 |
| Injection of trigger points, 3 or more muscles | 12 | $951 | $59 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 13 | $841 | $49 |
| Injection of drug or substance under skin or into muscle | 11 | $359 | $20 |
| Testing for presence of drug, read by direct observation | 18 | $277 | $13 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $128 | None |
| Injection, ketorolac tromethamine, per 15 mg | 11 | $33 | None |
2017: 12 services
| Short return visit (20+ min) | 165 | $29,645 | $63 |
| Return visit (30+ min) | 83 | $12,948 | $95 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 66 | $10,414 | $118 |
| New patient visit (45+ min) | 69 | $9,816 | $142 |
| New patient visit (30+ min) | 58 | $5,635 | $97 |
| Nerve test | 15 | $4,251 | $283 |
| Extended patient service without direct patient contact, first hour | 36 | $3,642 | $98 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 49 | $3,251 | $52 |
| Muscle electrical test | 21 | $2,930 | $89 |
| Injection of drug or substance under skin or into muscle | 22 | $683 | $24 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 20 | $114 | None |
| Injection, ketorolac tromethamine, per 15 mg | 20 | $54 | None |
2016: 9 services
| Short return visit (20+ min) | 93 | $18,170 | $67 |
| Return visit (30+ min) | 54 | $9,038 | $98 |
| New patient visit (45+ min) | 41 | $6,143 | $150 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 16 | $1,940 | $121 |
| New patient visit (30+ min) | 16 | $1,584 | $99 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 20 | $934 | $39 |
| Injection of drug or substance under skin or into muscle | 15 | $456 | $25 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $59 | None |
| Injection, ketorolac tromethamine, per 15 mg | 14 | $31 | None |
Drugs they prescribed that Part D paid
$48,029
Pharmacies billed $48,029 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 57% of their Part D prescriptions (327 of 578) in 2024. A higher opioid share than 9 in 10 peers; the typical physical medicine and rehabilitation clinician is at 12%. Long-acting opioids: 15% of their opioid prescriptions.
555 generic and 23 brand-name prescriptions · $48,029 in drug cost · 20 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 156 | $3,548 | $23 |
| Lidocaine | 19 | $2,889 | $152 |
| Oxycodone | 57 | $1,660 | $29 |
| Tramadol | 31 | $1,113 | $36 |
| Oxycodone-Acetaminophen | 27 | $1,080 | $40 |
See all 13 drugs
| Hydrocodone-Acetaminophen | 156 | $3,548 | $23 |
| Lidocaine | 19 | $2,889 | $152 |
| Oxycodone | 57 | $1,660 | $29 |
| Tramadol | 31 | $1,113 | $36 |
| Oxycodone-Acetaminophen | 27 | $1,080 | $40 |
| Celecoxib | 13 | $1,008 | $78 |
| Morphine Sulfate Er | 25 | $648 | $26 |
| Gabapentin | 55 | $542 | $10 |
| Pregabalin | 24 | $407 | $17 |
| Meloxicam | 17 | $207 | $12 |
| Methylprednisolone | 11 | $78 | $7 |
| Cephalexin | 12 | $53 | $4 |
| Cyclobenzaprine | 14 | $17 | $1 |
Year by year
| 2024 | 578 | 83 | 57% (327) | 4% | $48,029 |
| 2023 | 335 | 61 | 59% (199) | None | $30,693 |
| 2022 | 414 | 95 | 59% (244) | 8% | $41,382 |
| 2021 | 298 | 73 | 52% (156) | 10% | $42,087 |
| 2020 | 383 | 82 | 53% (204) | 5% | $71,233 |
| 2019 | 311 | 93 | 54% (169) | 8% | $18,054 |
| 2018 | 679 | 109 | 65% (443) | 10% | $49,118 |
| 2017 | 721 | 121 | 61% (441) | 7% | $51,171 |
| 2016 | 568 | 89 | 67% (379) | 7% | $34,192 |
| 2015 | 107 | 37 | 74% (79) | None | $4,395 |
| 2014 | 15 | None | 80% (12) | None | $948 |
| 2013 | 38 | None | 53% (20) | None | $2,706 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Hydrocodone-Acetaminophen | 95 | $2,088 | $22 |
| Tramadol | 17 | $1,019 | $60 |
| Oxycodone | 37 | $958 | $26 |
| Gabapentin | 39 | $628 | $16 |
| Oxycodone-Acetaminophen | 14 | $498 | $36 |
| Methocarbamol | 11 | $46 | $4 |
| Cyclobenzaprine | 11 | $39 | $4 |
2022: 9 drugs
| Oxycontin | 19 | $12,461 | $656 |
| Hydrocodone-Acetaminophen | 102 | $3,447 | $34 |
| Gabapentin | 41 | $1,461 | $36 |
| Oxycodone | 54 | $1,314 | $24 |
| Oxycodone-Acetaminophen | 17 | $899 | $53 |
| Cyclobenzaprine | 23 | $684 | $30 |
| Tramadol | 18 | $287 | $16 |
| Naproxen | 12 | $99 | $8 |
| Methylprednisolone | 14 | $92 | $7 |
2021: 9 drugs
| Nucynta Er | 13 | $23,844 | $1,834 |
| Hydrocodone-Acetaminophen | 69 | $1,610 | $23 |
| Duloxetine | 14 | $899 | $64 |
| Gabapentin | 21 | $688 | $33 |
| Oxycodone-Acetaminophen | 16 | $631 | $39 |
| Baclofen | 15 | $485 | $32 |
| Oxycodone | 24 | $432 | $18 |
| Cyclobenzaprine | 12 | $318 | $27 |
| Buprenorphine | 12 | $162 | $13 |
2020: 8 drugs
| Hydrocodone-Acetaminophen | 112 | $2,541 | $23 |
| Oxycodone-Acetaminophen | 26 | $1,104 | $42 |
| Gabapentin | 41 | $788 | $19 |
| Oxycodone | 16 | $461 | $29 |
| Cyclobenzaprine | 23 | $203 | $9 |
| Duloxetine | 13 | $132 | $10 |
| Cephalexin | 12 | $51 | $4 |
| Tramadol | 11 | $34 | $3 |
2019: 7 drugs
| Hydrocodone-Acetaminophen | 70 | $1,672 | $24 |
| Oxycodone | 41 | $1,420 | $35 |
| Gabapentin | 30 | $708 | $24 |
| Oxycodone-Acetaminophen | 15 | $525 | $35 |
| Tizanidine | 13 | $419 | $32 |
| Diclofenac | 16 | $291 | $18 |
| Cephalexin | 11 | $67 | $6 |
2018: 15 drugs
| Nucynta Er | 12 | $14,422 | $1,202 |
| Lyrica | 14 | $6,702 | $479 |
| Oxycontin | 17 | $5,031 | $296 |
| Hydrocodone-Acetaminophen | 169 | $4,489 | $27 |
| Oxycodone | 130 | $3,744 | $29 |
| Oxycodone-Acetaminophen | 44 | $1,675 | $38 |
| Morphine Sulfate Er | 23 | $1,100 | $48 |
| Gabapentin | 40 | $810 | $20 |
| Fentanyl | 12 | $754 | $63 |
| Cyclobenzaprine | 19 | $384 | $20 |
| Baclofen | 14 | $274 | $20 |
| Methadone | 15 | $145 | $10 |
| Tizanidine | 12 | $124 | $10 |
| Carisoprodol | 13 | $67 | $5 |
| Diazepam | 13 | $34 | $3 |
2017: 11 drugs
| Oxycontin | 13 | $7,045 | $542 |
| Oxycodone-Acetaminophen | 73 | $4,235 | $58 |
| Oxycodone | 89 | $3,636 | $41 |
| Hydrocodone-Acetaminophen | 163 | $3,006 | $18 |
| Fentanyl | 14 | $1,688 | $121 |
| Morphine Sulfate Er | 19 | $1,292 | $68 |
| Gabapentin | 75 | $1,274 | $17 |
| Cyclobenzaprine | 24 | $466 | $19 |
| Methadone | 22 | $389 | $18 |
| Acetaminophen-Codeine | 17 | $254 | $15 |
| Diazepam | 23 | $193 | $8 |
2016: 13 drugs
| Nucynta Er | 11 | $9,297 | $845 |
| Oxycodone-Acetaminophen | 105 | $6,730 | $64 |
| Metaxalone | 11 | $3,295 | $300 |
| Hydrocodone-Acetaminophen | 108 | $2,988 | $28 |
| Oxycodone | 43 | $1,960 | $46 |
| Morphine Sulfate Er | 28 | $1,752 | $63 |
| Fentanyl | 20 | $1,468 | $73 |
| Gabapentin | 45 | $808 | $18 |
| Acetaminophen-Codeine | 20 | $531 | $27 |
| Hydromorphone | 20 | $334 | $17 |
| Cyclobenzaprine | 13 | $93 | $7 |
| Tramadol | 12 | $73 | $6 |
| Diazepam | 13 | $60 | $5 |
2015: 2 drugs
| Oxycodone-Acetaminophen | 15 | $1,260 | $84 |
| Hydrocodone-Acetaminophen | 31 | $783 | $25 |
Money from drug and device companies
$168 in 2025
| 2025 | 5 | 5 | None | $168 |
| 2024 | 5 | 8 | None | $181 |
| 2023 | 6 | 15 | None | $417 |
| 2022 | 5 | 21 | None | $532 |
| 2021 | 7 | 77 | None | $1,093 |
| 2020 | 7 | 50 | None | $782 |
| 2019 | 5 | 71 | None | $2,575 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Mml US | Reactiv8 | $58 | 1 payment
|
| Si-Bone | None | $42 | 1 payment
|
| Boston Scientific | Intracept | $27 | 1 payment
|
| SPR Therapeutics | Sprint Pns System | $26 | 1 payment
|
| Curonix | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $14 | 1 payment
|
See all 5 published payments
| Mml US | Meals · 2025-09-25 | Reactiv8 | $58 |
| Curonix | Meals · 2025-07-17 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $14 |
| SPR Therapeutics | Meals · 2025-04-10 | Sprint Pns System | $26 |
| Si-Bone | Meals · 2025-03-25 | None | $42 |
| Boston Scientific | Meals · 2025-01-22 | Intracept | $27 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $181
| Boston Scientific | None | $87 | 3 payments
|
| Abbott Laboratories | Proclaim | $39 | 2 payments
|
| SPR Therapeutics | Sprint Pns System | $28 | 1 payment
|
| Si-Bone | None | $16 | 1 payment
|
| Vertos Medical | Mild Device Kit | $10 | 1 payment
|
2023: $417
| Boston Scientific | None | $152 | 7 payments
|
| Relievant Medsystems | Intracept | $96 | 1 payment
|
| SPR Therapeutics | Sprint Pns System | $73 | 3 payments
|
| Vertos Medical | Mild Device Kit | $60 | 2 payments
|
| Saluda Medical Americas | Evoke Scs | $22 | 1 payment
|
| Electronic Waveform Lab | None | $13 | 1 payment
|
2022: $532
| Boston Scientific | General - Pain Management | $289 | 14 payments
|
| Stimwave Technologies | Stimq Receiver Stimulator Kit Channel A US W/Receiver | $172 | 3 payments
|
| Hikma Pharmaceuticals USA | Kloxxado | $36 | 2 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $20 | 1 payment
|
| Vertos Medical | Mild Device Kit | $14 | 1 payment
|
2021: $1,093
| Boston Scientific | Wavewriter Alpha | $668 | 67 payments
|
| Painteq | Painteq | $179 | 3 payments
|
| Stimwave Technologies | Stimq Receiver Stimulator Kit Channel A US W Receiver | $164 | 3 payments
|
| Vertos Medical | Mild Device Kit | $29 | 1 payment
|
| Biohaven Pharmaceuticals | Nurtec Odt | $19 | 1 payment
|
| Relievant Medsystems | Intracept | $18 | 1 payment
|
| AbbVie | Ubrelvy | $17 | 1 payment
|
2020: $782
| Boston Scientific | General - Pain Management | $527 | 39 payments
|
| Stimwave Technologies | Stimq Peripheral Nerve Stimulatorsystem | $114 | 6 payments
|
| SPR Therapeutics | Sprint Pns System | $42 | 1 payment
|
| Vertos Medical | Mild Device Kit | $38 | 1 payment
|
| Allergan | Botox | $22 | 1 payment
|
| Spinal Simplicity | Minuteman | $22 | 1 payment
|
| Medtronic USA | Mystim | $17 | 1 payment
|
2019: $2,575
| Boston Scientific | General Pain Management | $1,155 | 54 payments
|
| Vertiflex | Superion Iss | $924 | 10 payments
|
| Stimwave Technologies | None | $329 | 4 payments
|
| SPR Therapeutics | Sprint Pns System | $146 | 2 payments
|
| Indivior | Sublocade | $21 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Stimwave Technologies Incorporated · Freedom-1 Study for Chronic Knee Pain · 2021 | Their institution | $1,250 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1205033594
- Licence
- CA A105629, TX M6924California A105629: Current · expires 2028-03-31Texas M6924: Canc Non-Renewal
- Trained
- Temple University School of Medicine, 2003
- Group
- James Petros MD Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- TX 187646801
- Taxonomy
- Federal specialty code 208100000X (208100000X)
- Mailing address
- 92 Corporate Park, Suite C-330, Irvine, CA, 92606
- NPI first listed
- 2007-06-29
- NPI last updated
- 2014-04-02
This is when the NPI record was last certified, not a medical board exam.